Publications

This fact sheet for providers outlines the changes to human papillomavirus (HPV) vaccination under the National Immunisation Program (NIP) in 2023.

AusVaxSafety is a national system monitoring vaccine safety in Australia. The report shows how people receiving vaccines, or their parents and carers, responded to the SMS about their health a few days after vaccination at each schedule point in the National Immunisation Program in Australia 2020.

AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their vaccinations.

AusVaxSafety is a national system monitoring vaccine safety in Australia. The report shows how people receiving vaccines, or their parents and carers, responded to the SMS about their health a few days after vaccination at each schedule point in the National Immunisation Program in Australia 2019.

Historical reports showing national human papillomavirus (HPV) vaccination coverage by remoteness of the area of residence.

Historical reports showing national human papillomavirus (HPV) vaccination coverage for the the female catch up cohort by dose number (1, 2 or 3) and single age cohort (12-26 years) for the specified year.

This document outlines changes to the recommended use of human papillomavirus (HPV) vaccines in The Australian Immunisation Handbook 10th Edition proposed in 2017. It includes the outcome of public consultations and the final recommendation made to the National Health and Medical Research Council.

Australian Technical Advisory Group on Immunisation (ATAGI) advice on the introduction of Gardasil®9 in a 2-dose schedule under the school-based National Immunisation Program (NIP).

The evaluation was extremely positive and strongly supported Australia’s reputation as a world leader in implementing school-based immunisation programs and preventing HPV-related cancers and disease.